DSM, private equity firm, buy drugmaker Patheon

AP News
|
Posted: Nov 19, 2013 9:51 AM

AMSTERDAM (AP) — Dutch chemicals maker Royal DSM NV and private equity firm JLL are teaming up to buy Canada's Patheon Inc. for $195 million (145 million euros) so they can combine it with DSM's pharmaceuticals arm and then spin off the new combination as a separate company.

Under the deal announced Tuesday, JLL will contribute $489 million to the new company, with the funds used to buy Patheon and pay DSM $200 million. After the deal, JLL will own 51 percent of the new entity, and DSM will own 49 percent.

Recommended
15 Days Till Trump Crushes Them Again
Kevin McCullough

Patheon's managers, who own a majority of their company, have agreed to the firms' $9.32 per share takeover offer. That's a 64 percent premium to Patheon's closing price Monday.